{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:56:00Z","timestamp":1773928560767,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172847"],"award-info":[{"award-number":["82172847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.urolonc.2025.11.007","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:31:18Z","timestamp":1764973878000},"page":"126.e11-126.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Somatic alterations of genitourinary malignancy of Chinese population based on tumor NGS data"],"prefix":"10.1016","volume":"44","author":[{"given":"Xin","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5079-402X","authenticated-orcid":false,"given":"Shaochen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqiang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.urolonc.2025.11.007_bib0001","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0002","series-title":"WHO methods and data sources for global burden of disease estimates 2000\u20132011","first-page":"7","year":"2013"},{"issue":"1","key":"10.1016\/j.urolonc.2025.11.007_bib0003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Nat Cancer Center"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40779-021-00354-z","article-title":"Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990\u20132019","volume":"8","author":"Zi","year":"2021","journal-title":"Military Med Res"},{"issue":"3","key":"10.1016\/j.urolonc.2025.11.007_bib0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J Clin"},{"issue":"1","key":"10.1016\/j.urolonc.2025.11.007_bib0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.11.007_bib0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clgc.2018.10.002","article-title":"Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-based study","volume":"17","author":"Saad","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2025.11.007_bib0008","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.11.007_bib0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/clpt.2014.5","article-title":"Race and ethnicity in cancer therapy: what have we learned?","volume":"95","author":"Grenade","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.urolonc.2025.11.007_bib0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","article-title":"Intratumor heterogeneity: the Rosetta stone of therapy resistance","volume":"37","author":"Marusyk","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.urolonc.2025.11.007_bib0011","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41571-018-0002-6","article-title":"The emerging clinical relevance of genomics in cancer medicine","volume":"15","author":"Berger","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.11.007_bib0012","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat Med"},{"issue":"30","key":"10.1016\/j.urolonc.2025.11.007_bib0013","doi-asserted-by":"crossref","first-page":"11139","DOI":"10.1073\/pnas.1411446111","article-title":"Copy number alteration burden predicts prostate cancer relapse","volume":"111","author":"Hieronymus","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.urolonc.2025.11.007_bib0014","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.urolonc.2025.11.007_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"17","key":"10.1016\/j.urolonc.2025.11.007_bib0016","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0017","doi-asserted-by":"crossref","first-page":"589\u2011595","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long\u2011read alignment with Burrows\u2011Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0018","article-title":"gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data","author":"Chen","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0019","article-title":"1000 Genome Project Data Processing Subgroup: the sequence alignment\/map (SAM) format and SAMtools","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.urolonc.2025.11.007_bib0020","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0021","unstructured":"Golden helix genomebrowse \u00ae visualization tool (Version 2.x) [Software]. Bozeman, MT: Golden Helix, Inc. Available from http:\/\/www.goldenhelix.com."},{"issue":"16","key":"10.1016\/j.urolonc.2025.11.007_bib0022","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.urolonc.2025.11.007_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted sequencing","volume":"12","author":"Talevich","year":"2014","journal-title":"PLOS Computational Biol"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0024","doi-asserted-by":"crossref","unstructured":"Chen S., Qu H., Yang B., et al. Detect and visualize tumor microsatellite instability status from next-generation sequencing data by simulating PCR techniques. 2019: e13052\u2013e13052. https:\/\/github.com\/OpenGene\/VisualMSI","DOI":"10.1200\/JCO.2019.37.15_suppl.e13052"},{"issue":"3","key":"10.1016\/j.urolonc.2025.11.007_bib0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: a language for data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Computation Graphical Statist"},{"issue":"18","key":"10.1016\/j.urolonc.2025.11.007_bib0026","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.urolonc.2025.11.007_bib0027","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0028","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2009"},{"issue":"6","key":"10.1016\/j.urolonc.2025.11.007_bib0029","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.urolonc.2025.11.007_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"issue":"7471","key":"10.1016\/j.urolonc.2025.11.007_bib0031","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0032","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2025.11.007_bib0033","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.urolonc.2025.11.007_bib0034","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/path.1481","article-title":"High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer","volume":"201","author":"Zaharieva","year":"2003","journal-title":"J Pathol: J Pathologic Society Great Britain and Ireland"},{"issue":"4","key":"10.1016\/j.urolonc.2025.11.007_bib0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 expression as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"24","key":"10.1016\/j.urolonc.2025.11.007_bib0036","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1158\/1078-0432.CCR-21-0972","article-title":"Association of AXL and PD-L1 expression with clinical outcomes in patients with advanced renal cell carcinoma treated with PD-1 blockade","volume":"27","author":"Terry","year":"2021","journal-title":"Clin Can Res"},{"issue":"10","key":"10.1016\/j.urolonc.2025.11.007_bib0037","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/1878-0261.13511","article-title":"Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity","volume":"17","author":"Wei","year":"2023","journal-title":"Molecul Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.11.007_bib0038","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/aja202259","article-title":"FOXA1 in prostate cancer","volume":"25","author":"Dong","year":"2023","journal-title":"Asian J Androl"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:38:46Z","timestamp":1773916726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1078143925004697"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.11.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic alterations of genitourinary malignancy of Chinese population based on tumor NGS data","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}